Study identifies new mechanisms that boost p53 signaling and tumor suppression

A team led by Ludwig Stanford’s Laura Attardi explored novel mechanisms by which the p53 protein, often called the guardian of the genome, regulates gene expression by looking for novel proteins that interact with the versatile tumor suppressor in response to cellular stressors. The researchers isolated these proteins based on their binding to p53 and identified them by mass spectroscopy. They reported in a May publication in Molecular Cell that METTL3—a key component of an mRNA-modifying protein complex known as M6A RNA methyltransferase complex (MTC) that helps regulate gene expression—amplifies p53 signaling induced by cellular stress. The researchers showed that METTL3 helps to stabilize p53 and promotes the expression of its target genes in response to DNA damage and oncogenic signaling by more than one mechanism. Indeed, p53 is relatively less stable and adept at inducing its target genes in cells that are deficient in METTL3. Laura and her colleagues also showed that METTL3 enhances the tumor suppressing activity of p53 in human cancer cells and in mouse models of cancer. Finally, their analysis of human cancer genome data supports a role for MTC in reinforcing p53 function in cancer.

Read the study: The Mettl3 epitranscriptomic writer amplifies p53 stress responses, Molecular Cell, 2022 May 4 Epub

This article appeared in the September 2022 issue of Ludwig Link. Click here to download a PDF (1 MB).


You are now leaving Ludwig Cancer Research's website and are going to a website that is not operated by the association. We are not responsible for the content or availability of linked sites. Do you wish to continue?